Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

Journal of the National Cancer Institute

Volumn 108, Issue 6, 2016, Pages

  Anglesio, Michael S ^a,b   Wang, Yi Kan ^c   Maassen, Madlen ^d   Horlings, Hugo M ^a   Bashashati, Ali ^c   Senz, Janine ^a   Mackenzie, Robertson ^c   Grewal, Diljot S ^c   Li Chang, Hector ^a   Karnezis, Anthony N ^a   Sheffield, Brandon S ^a   McConechy, Melissa K ^a   Kommoss, Friedrich ^e   Taran, Florin A ^d   Staebler, Annette ^d   Shah, Sohrab P ^c   Wallwiener, Diethelm ^d   Brucker, Sara ^d   Gilks, C Blake ^f   Kommoss, Stefan ^d   Huntsman, David G ^a,b   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLONAL VARIATION; DISTANT METASTASIS; ENDOMETRIUM CARCINOMA; EPIGENETICS; EXOME; FEMALE; GENE DELETION; GENE DOSAGE; GENE FREQUENCY; GENE INSERTION; GENE MUTATION; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; SURFACE PROPERTY; SYNCHRONOUS ENDOMETRIAL AND OVARIAN TUMOR; TUMOR GENE; TUMOR MICROENVIRONMENT; CANCER GRADING; CELL CLONE; DNA SEQUENCE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; GENETICS; MULTIPLE CANCER; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROCEDURES; SAMPLE SIZE;

DNA;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; CLONE CELLS; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; EXOME; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; SAMPLE SIZE; SEQUENCE ANALYSIS, DNA;

EID: 84977119175     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv428     Document Type: Article

References (30)

1. Chui MH, Ryan P, Radigan J, et al. The histomorphology of Lynch syndromeassociated ovarian carcinomas: toward a subtype-specific screening strategy. Am J Surg Pathol. 2014;38(9):1173-1181.
2. Heitz F, Amant F, Fotopoulou C, et al. Synchronous ovarian and endometrial cancer-an international multicenter case-control study. Int J Gynecol Cancer. 2014;24(1):54-60.
3. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol. 1985;16(1):28-34.
4. Takeshima N, Hirai Y, Yano K, et al. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol. 1998;70(2):183-187.
5. Falkenberry SS, Steinhoff MM, Gordinier M, et al. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases. J Reprod Med. 1996;41(10):713-718.
6. Ramus SJ, Elmasry K, Luo Z, et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin Cancer Res. 2008;14(18):5840-5848.
7. Talhouk A, McConechy MK, Leung S, et al. A clinically applicable molecularbased classification for endometrial cancers. Br J Cancer. 2015;113(2):299-310.
8. McConechy MK, Ding J, Senz J, et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 2014;27(1):128-134.
9. McConechy MK, Ding J, Cheang MC, et al. Use of mutation profiles to refine the classification of endometrial carcinomas. J Pathol. 2012;228(1):20-30.
10. McConechy MK, Anglesio MS, Kalloger SE, et al. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol. 2011;223(5):567-573.
11. Cancer Genome Atlas Research N, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73.
12. Mackenzie R, Talhouk A, Eshragh S, et al. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. Am J Surg Pathol. 2015;39(11):1548-1557.
13. Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532-1543.
14. Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609-615.
15. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. In. WHO Classification of Tumours. 4 ed. Lyon, France: IARC-WHO Press; 2014, 316.
16. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Third Series ed. Washington, DC: Armed Forces Institute of Pathology (US); 1998.
17. Forbes SA, Bindal N, Bamford S, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011;39(Database issue):D945-D950.
18. Do H, Dobrovic A. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin Chem. 2015;61(1):64-71.
19. Hoang LN, McConechy MK, Kobel M, et al. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Int J Gynecol Cancer. 2015;25(7):1187-1193.
20. Church DN, Briggs SE, Palles C, et al. DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer. Hum Mol Genet. 2013;22(14):2820-2828.
21. Schultheis AM, Ng CKY, Filippo MRD, et al. Sporadic synchronous endometrioid endometrial and ovarian carcinomas are clonally related. J Natl Cancer Inst. 2016;108(6):djv427 doi:10.1093/jnci/djv427.
22. Tan DS, Iravani M, McCluggage WG, et al. Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas. Clin Cancer Res. 2011;17(6):1521-34.
23. Bashashati A, Ha G, Tone A, et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol. 2013;231(1):21-34.
24. Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151-160.
25. Lalwani N, Prasad SR, Vikram R, et al. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 2011;31(3):625-646.
26. Ayhan A, Gultekin M, Celik NY, et al. Occult metastasis in early ovarian cancers: risk factors and associated prognosis. Am J Obstet Gynecol. 2007;196(1):81,e1-e6.
27. Vinokurova S, Wentzensen N, Einenkel J, et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J Natl Cancer Inst. 2005;97(24):1816-1821.
28. Ronnett BM, Yemelyanova AV, Vang R, et al. Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms. Am J Surg Pathol. 2008;32(12):1835-1853.
29. Hartmann A, Rosner U, Schlake G, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest. 2000;80(5):709-718.
30. Anglesio MS, Bashashati A, Wang YK, et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J Pathol. 2015;236(2):201-209.